A detailed history of Jane Street Group, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 85,323 shares of CYTK stock, worth $4.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,323
Previous 265,002 67.8%
Holding current value
$4.17 Million
Previous $14.4 Million 68.62%
% of portfolio
0.0%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $9.2 Million - $10.8 Million
-179,679 Reduced 67.8%
85,323 $4.51 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $2.04 Million - $3.19 Million
-42,565 Reduced 13.84%
265,002 $14.4 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $14 Million - $23.7 Million
218,986 Added 247.22%
307,567 $21.6 Million
Q4 2023

Feb 14, 2024

SELL
$26.88 - $83.49 $980,017 - $3.04 Million
-36,459 Reduced 29.16%
88,581 $7.4 Million
Q3 2023

Nov 14, 2023

SELL
$29.46 - $36.61 $658,313 - $818,087
-22,346 Reduced 15.16%
125,040 $3.68 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $2.17 Million - $2.71 Million
66,574 Added 82.38%
147,386 $4.81 Million
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $3.18 Million - $4.36 Million
-95,292 Reduced 54.11%
80,812 $2.84 Million
Q4 2022

Feb 14, 2023

SELL
$35.77 - $51.11 $6.53 Million - $9.34 Million
-182,648 Reduced 50.91%
176,104 $8.07 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $9.04 Million - $12.8 Million
234,502 Added 188.73%
358,752 $17.4 Million
Q2 2022

Aug 16, 2022

BUY
$33.93 - $48.92 $2.26 Million - $3.25 Million
66,491 Added 115.12%
124,250 $4.88 Million
Q1 2022

May 17, 2022

SELL
$29.74 - $46.0 $134,097 - $207,414
-4,509 Reduced 7.24%
57,759 $2.13 Million
Q4 2021

Feb 15, 2022

BUY
$34.35 - $46.38 $1.76 Million - $2.38 Million
51,279 Added 466.64%
62,268 $2.84 Million
Q3 2021

Nov 16, 2021

SELL
$18.54 - $35.74 $61,478 - $118,513
-3,316 Reduced 23.18%
10,989 $393,000
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $1.41 Million - $1.92 Million
-71,035 Reduced 83.24%
14,305 $283,000
Q4 2020

Feb 17, 2021

BUY
$15.26 - $28.61 $449,895 - $843,480
29,482 Added 52.78%
85,340 $1.77 Million
Q3 2020

Nov 17, 2020

BUY
$20.58 - $28.96 $942,090 - $1.33 Million
45,777 Added 454.09%
55,858 $1.21 Million
Q2 2020

Aug 17, 2020

SELL
$11.15 - $24.64 $527,629 - $1.17 Million
-47,321 Reduced 82.44%
10,081 $238,000
Q4 2019

Feb 14, 2020

BUY
$7.95 - $11.84 $456,345 - $679,639
57,402 New
57,402 $609,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.